Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Shuster

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Journal of Pediatric Hematology/Oncology|March 1, 2000
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group studyA F Mulne, J M Ducore, R D Elterman, et al.
Leukemia|June 1, 1992
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group studyJ M Falletta, J J Shuster, W M Crist, et al.
Medical and Pediatric Oncology|October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology GroupM L Brecher, M R Schwenn, M J Coppes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
The prognostic significance of autologous bone marrow transplant in advanced neuroblastomaJ J Shuster, A B Cantor, N McWilliams, et al.
Cancer|February 1, 1991
A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group studyR A Krance, E M Newman, Y Ravindranath, et al.
Investigational New Drugs|December 4, 2013
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumorsE M Dunbar, B S Coats, A L Shroads, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastomaR P Castleberry, L E Kun, J J Shuster, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 1998
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology GroupS S Donaldson, M Torrey, M P Link, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1996
Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group studyP L Martin, A T Look, S Schnell, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Journal of Pediatric Hematology/Oncology|March 1, 2000
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group studyA F Mulne, J M Ducore, R D Elterman, et al.
Leukemia|June 1, 1992
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group studyJ M Falletta, J J Shuster, W M Crist, et al.
Medical and Pediatric Oncology|October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology GroupM L Brecher, M R Schwenn, M J Coppes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
The prognostic significance of autologous bone marrow transplant in advanced neuroblastomaJ J Shuster, A B Cantor, N McWilliams, et al.
Cancer|February 1, 1991
A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group studyR A Krance, E M Newman, Y Ravindranath, et al.
Investigational New Drugs|December 4, 2013
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumorsE M Dunbar, B S Coats, A L Shroads, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastomaR P Castleberry, L E Kun, J J Shuster, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 1998
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology GroupS S Donaldson, M Torrey, M P Link, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1996
Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group studyP L Martin, A T Look, S Schnell, et al.
Pageof 16